#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Chorioretinitis Hypoparathyroidism Sarcoma Breast cancer metastatic Pulmonary sarcoidosis Hereditary neuropathic amyloidosis Heart disease congenital Liposarcoma metastatic Retinopathy proliferative Synovitis Acute promyelocytic leukaemia Candida infection Neutropenia Systemic mastocytosis More trials…

    Learn about Rare Diseases

    Epidermolysis bullosa – Basic Information Glycogen storage disease type V – Diagnostics Richter’s syndrome Uterine leiomyosarcoma – Trials in Disease Retinoblastoma – Basic Information Lymphangiosarcoma – Diagnostics Haemophilia B with anti factor IX – Diagnostics KBG syndrome – Life with Disease Friedreich’s ataxia – Treatment Myxofibrosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acetylsalicylic Acid Ph. Eur. Fenofibrate Micronised Vo659 Avelumab Mebendazole Bms-986315 Olorofim AZD0516 Ale.c04 Fluoroestradiol F-18 [14C]ZIPALERTINIB Threonine Valproic Acid Narsoplimab Letetresgene Autoleucel Cyanocobalamin Loncastuximab Tesirine Metoclopramide Hydrochloride Doxylamine Hydrogen Succinate Cilazapril More therapies…

    Learn about Your Condition

    Arteriospasm coronary Myofascial pain syndrome Allergic respiratory disease Anaemia of chronic disease Incontinence Insomnia Metabolic disorder Hepatic angiosarcoma Osteotomy Epstein-Barr virus infection Endocrine disorder Diabetic foot Pelizaeus-Merzbacher disease Systemic infection Hepatotoxicity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Gallbladder cancer
    • B-cell lymphoma
    • Bladder cancer
    Investigated Drugs:
    • Cyc140 Monohydrochloride Monohydrate
    Spain

  • Study of Nous-209 Genetic Vaccine and Pembrolizumab for Patients with Advanced Microsatellite Instability-High Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Gad20-209-Fsp-A1
    • Gad20-209-Fsp-A2
    • Gad20-209-Fsp-A3
    Belgium Italy Spain

  • Study of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study on the Safety and Effectiveness of Binimetinib, Lapatinib, and Vinorelbine for Patients with RAS-Mutated Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Lapatinib
    • Binimetinib
    • Vinorelbine
    The Netherlands

  • Study Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Regorafenib
    • Panitumumab
    Italy

  • Study on the Safety and Effectiveness of Trifluridine/Tipiracil, Capecitabine, and Bevacizumab for Patients with Metastatic Colorectal Cancer Unfit for Intensive Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    Italy
Previous Page
1 … 10 11 12 13 14 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!